Report
Mayo Clinic advances understanding of senescent cells and aging-related inflammation
Seven Mayo Clinic studies in Nature journals introduce tools for identifying senescent ('zombie') cells—aging cells that stop dividing but remain active and secrete inflammatory molecules. Key advances include the SenMayo gene set and preclinical tests of interventions including tomato-derived compounds.
TLDR
Senescent cells are linked to frailty, chronic disease, and age-related conditions. Mayo Clinic's studies provide mechanistic insights into how cells drive inflammation through mitochondrial pathways and offer potential therapeutic targets. Building on prior senolytic research, findings fuel optimism for aging interventions and inflammation-driven disease prevention.
Combined views
37
2 Sources, first seen ago